牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

近岸蛋白（688137）

5.0

综合诊断：5.0分打败了56%的股票！

卖出
减持
中性
增持
买入

短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
中期趋势：
正处于反弹阶段。
长期趋势：
已有55家主力机构披露2025-12-31报告期持股数据，持仓量总计1500.40万股，占流通A股45.92%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

5.4分

5.5分

2.8分

4.8分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：5.4技术面打败了60%的股票技术面评分前10的股票

近期的平均成本为37.57元。空头行情中，目前正处于反弹阶段，投资者可适当关注。

技术面得分最高的股票

平均成本

近期的平均成本为37.57元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"37.57","date":1784190558,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势接近大盘，接近行业平均水平。

[{"date":"2026.07.17","stock":"-7.96","trade":"-7.01","ind":"-3.05"},{"date":"2026.07.16","stock":"-0.18","trade":"0.36","ind":"-1.85"},{"date":"2026.07.15","stock":"-0.07","trade":"2.67","ind":"-0.29"},{"date":"2026.07.14","stock":"2.64","trade":"2.74","ind":"1.36"},{"date":"2026.07.13","stock":"0.00","trade":"-1.36","ind":"-2.06"},{"date":"2026.07.10","stock":"4.64","trade":"3.33","ind":"-1.00"},{"date":"2026.07.09","stock":"1.11","trade":"0.10","ind":"1.65"},{"date":"2026.07.08","stock":"-3.36","trade":"-1.54","ind":"-0.49"},{"date":"2026.07.07","stock":"-1.98","trade":"-4.28","ind":"-1.26"},{"date":"2026.07.06","stock":"0.72","trade":"1.41","ind":"-0.06"},{"date":"2026.07.03","stock":"1.02","trade":"1.88","ind":"0.37"},{"date":"2026.07.02","stock":"1.97","trade":"-0.24","ind":"-2.03"},{"date":"2026.07.01","stock":"4.17","trade":"4.33","ind":"0.44"},{"date":"2026.06.30","stock":"-0.69","trade":"-0.54","ind":"0.50"},{"date":"2026.06.29","stock":"7.66","trade":"7.43","ind":"1.16"},{"date":"2026.06.26","stock":"-4.43","trade":"-3.87","ind":"-2.26"},{"date":"2026.06.25","stock":"-1.59","trade":"-1.00","ind":"0.23"},{"date":"2026.06.24","stock":"-2.72","trade":"-1.03","ind":"0.11"},{"date":"2026.06.23","stock":"4.13","trade":"2.96","ind":"-1.37"},{"date":"2026.06.22","stock":"-1.78","trade":"-0.76","ind":"1.78"},{"date":"2026.06.18","stock":"3.36","trade":"1.76","ind":"-0.43"}]

近岸蛋白,上证指数,生物制品指数

压力支撑

该股压力位为37.52元，支撑位为35.34元。

[{"text":"\u538b\u529b\u4f4d","value":"37.52","date":1784217600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"35.34","date":1784217600,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.4资金面打败了73%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体无进出。

更新时间：07月17日 20:31

机构今日流向(万元)	-2585.41	机构5日流向(万元)	515.96
机构10日流向(万元)	41.28	机构20日流向(万元)	1728.64

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加90.90万股，其中基金净减仓17家，主力净增仓16家，请投资者中长期谨慎为宜。

截止2025-12-31，共55家主力机构（基金52家，一般法人3家），持仓量总计1500.4万股，占流通A股45.92%
其中，基金持仓与2025-06-30相比：
增仓：2家，增持 23.35万股
减仓：19家，减持 66.83万股
新出现在主力名单中：29家，持有204.59万股
从主力名单中消失：13家，原持有54.01万股

消息面诊股

诊断结果：5.5消息面打败了63%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向		2026-06-01
一般消息	股东大会	年度股东大会	2026-04-29
一般消息	分红转增	不分配不转增	2026-04-29
重大利空	业绩预告	预计增亏	2026-01-31
一般消息	高管变动	取消监事会	2025-12-10
一般消息	分红转增	不分配不转增	2025-08-28

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	1条	1条	0条

行业面诊股

诊断结果：2.8行业面打败了47%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，接近大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2026.07.17","price":"-3.05","value":"-7.01"},{"date":"2026.07.16","price":"-1.85","value":"0.36"},{"date":"2026.07.15","price":"-0.29","value":"2.67"},{"date":"2026.07.14","price":"1.36","value":"2.74"},{"date":"2026.07.13","price":"-2.06","value":"-1.36"},{"date":"2026.07.10","price":"-1.00","value":"3.33"},{"date":"2026.07.09","price":"1.65","value":"0.10"},{"date":"2026.07.08","price":"-0.49","value":"-1.54"},{"date":"2026.07.07","price":"-1.26","value":"-4.28"},{"date":"2026.07.06","price":"-0.06","value":"1.41"},{"date":"2026.07.03","price":"0.37","value":"1.88"},{"date":"2026.07.02","price":"-2.03","value":"-0.24"},{"date":"2026.07.01","price":"0.44","value":"4.33"},{"date":"2026.06.30","price":"0.50","value":"-0.54"},{"date":"2026.06.29","price":"1.16","value":"7.43"},{"date":"2026.06.26","price":"-2.26","value":"-3.87"},{"date":"2026.06.25","price":"0.23","value":"-1.00"},{"date":"2026.06.24","price":"0.11","value":"-1.03"},{"date":"2026.06.23","price":"-1.37","value":"2.96"},{"date":"2026.06.22","price":"1.78","value":"-0.76"},{"date":"2026.06.18","price":"-0.43","value":"1.76"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	四环生物	24.68%	-4.19%	5.7分
2	艾迪药业	22.20%	7.26%	6.6分
3	百普赛斯	19.71%	-4.45%	5.6分
4	康辰药业	17.48%	7.14%	6.9分
5	君实生物	16.65%	-6.65%	5.4分
6	赛升药业	15.71%	-3.08%	4.9分
7	义翘神州	15.13%	-0.44%	6.0分
8	昊帆生物	13.60%	-9.66%	5.5分
9	甘李药业	13.35%	-3.31%	6.0分
10	长春高新	13.07%	4.29%	5.4分
11	迈威生物	13.06%	-2.73%	5.7分
12	我武生物	13.03%	0.93%	5.7分
13	康弘药业	11.26%	-1.21%	5.7分
14	诺诚健华	11.15%	-10.95%	5.4分
15	禾元生物	10.95%	0.89%	5.6分
16	上海莱士	10.17%	11.14%	6.0分
17	三生国健	9.76%	-16.53%	5.2分
18	双成药业	8.60%	-9.38%	5.6分
19	智翔金泰	8.60%	-3.89%	5.2分
20	诺唯赞	7.38%	-6.53%	5.7分
21	通化东宝	7.37%	-1.23%	6.3分
22	安科生物	6.65%	-0.61%	6.5分
23	神州细胞	6.26%	-2.86%	6.0分
24	博晖创新	5.84%	3.52%	5.4分
25	康泰生物	5.38%	2.45%	5.9分
26	科兴制药	4.98%	-10.41%	5.2分
27	辽宁成大	4.46%	4.36%	6.0分
28	西藏药业	4.08%	0.71%	6.0分
29	沃森生物	3.90%	-2.59%	5.7分
30	百克生物	3.58%	0.27%	5.5分
31	百奥泰	3.46%	-5.36%	5.6分
32	优宁维	3.28%	0.83%	5.6分
33	特宝生物	3.06%	3.29%	6.1分
34	华兰生物	2.65%	2.97%	5.8分
35	近岸蛋白	2.14%	-5.77%	5.0分
36	金迪克	1.82%	-6.56%	4.3分
37	天坛生物	1.71%	3.64%	5.5分
38	华兰疫苗	1.70%	-0.89%	5.5分
39	荣昌生物	1.34%	-13.44%	5.7分
40	-	1.08%	-7.84%	分
41	智飞生物	0.49%	0.82%	5.5分
42	博雅生物	-0.13%	6.53%	5.8分
43	成大生物	-0.40%	0.20%	5.1分
44	康希诺	-0.76%	-3.37%	4.8分
45	康华生物	-1.34%	-4.11%	5.4分
46	-	-5.29%	7.65%	分
47	卫光生物	-5.64%	-1.04%	5.0分
48	-	-6.18%	-18.63%	分
49	*ST未名	-7.63%	10.00%	5.0分
50	东宝生物	-8.04%	-4.37%	5.1分
51	派林生物	-9.99%	5.53%	5.9分
52	欧林生物	-14.82%	-31.48%	5.1分
53	万泽股份	-25.83%	-17.55%	5.0分
54	赛伦生物	-31.59%	-15.85%	4.3分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.8基本面打败了13%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（72.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：很强，居行业前列，两项指标的行业排名分别为 39/71 ， 30/71。

[{"date":"2026-03-31","value":"-0.52","vol":"-6.01"},{"date":"2025-12-31","value":"-3.76","vol":"-12.99"},{"date":"2025-09-30","value":"-1.38","vol":"-10.09"},{"date":"2025-06-30","value":"-1.16","vol":"-0.66"},{"date":"2025-03-31","value":"-0.56","vol":"-0.34"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	-0.52	-3.76	-1.38	-1.16	-0.56
行业(%)	-6.01	-12.99	-10.09	-0.66	-0.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"70.29","vol":"61.43"},{"date":"2025-12-31","value":"67.12","vol":"66.53"},{"date":"2025-09-30","value":"64.84","vol":"67.71"},{"date":"2025-06-30","value":"64.47","vol":"66.67"},{"date":"2025-03-31","value":"62.26","vol":"38.38"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	70.29	67.12	64.84	64.47	62.26
行业(%)	61.43	66.53	67.71	66.67	38.38

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 23/71 ， 22/71。

[{"date":"2026-03-31","value":"11.37","vol":"297.05"},{"date":"2025-12-31","value":"14.80","vol":"39.85"},{"date":"2025-09-30","value":"21.48","vol":"45.81"},{"date":"2025-06-30","value":"20.85","vol":"6902.14"},{"date":"2025-03-31","value":"28.20","vol":"6125.11"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	11.37	14.80	21.48	20.85	28.20
行业(%)	297.05	39.85	45.81	6902.14	6125.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"10.20","vol":"74.22"},{"date":"2025-12-31","value":"-42.94","vol":"33.79"},{"date":"2025-09-30","value":"-58.06","vol":"45.67"},{"date":"2025-06-30","value":"-172.00","vol":"5.21"},{"date":"2025-03-31","value":"-348.91","vol":"-8.79"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	10.20	-42.94	-58.06	-172.00	-348.91
行业(%)	74.22	33.79	45.67	5.21	-8.79

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，两项指标的行业排名分别为 48/71 ， 33/71。

[{"date":"2026-03-31","value":"0.02","vol":"0.06"},{"date":"2025-12-31","value":"0.07","vol":"0.29"},{"date":"2025-09-30","value":"0.05","vol":"0.21"},{"date":"2025-06-30","value":"0.03","vol":"0.13"},{"date":"2025-03-31","value":"0.02","vol":"0.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.02	0.07	0.05	0.03	0.02
行业(次)	0.06	0.29	0.21	0.13	0.06

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.17","vol":"0.29"},{"date":"2025-12-31","value":"0.69","vol":"1.29"},{"date":"2025-09-30","value":"0.54","vol":"0.90"},{"date":"2025-06-30","value":"0.36","vol":"0.55"},{"date":"2025-03-31","value":"0.17","vol":"0.25"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.17	0.69	0.54	0.36	0.17
行业(次)	0.29	1.29	0.90	0.55	0.25

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-37.80","vol":"-78.67"},{"date":"2025-12-31","value":"11.96","vol":"12.85"},{"date":"2025-09-30","value":"-8.59","vol":"0.21"},{"date":"2025-06-30","value":"-2.09","vol":"-1377.65"},{"date":"2025-03-31","value":"-39.69","vol":"-2083.82"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-37.80	11.96	-8.59	-2.09	-39.69
行业	-78.67	12.85	0.21	-1377.65	-2083.82

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"2.43","vol":"1.74"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.53","vol":"1.55"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	2.43	-	1.53	-
行业	0.00	1.74	0.00	1.55	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 48/71 ， 45/71。

[{"date":"2026-03-31","value":"23.22","vol":"6.66"},{"date":"2025-12-31","value":"26.84","vol":"5.80"},{"date":"2025-09-30","value":"25.67","vol":"6.07"},{"date":"2025-06-30","value":"25.93","vol":"6.57"},{"date":"2025-03-31","value":"25.98","vol":"7.73"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	23.22	26.84	25.67	25.93	25.98
行业	6.66	5.80	6.07	6.57	7.73

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"10.69","vol":"5.14"},{"date":"2025-12-31","value":"11.23","vol":"4.43"},{"date":"2025-09-30","value":"11.73","vol":"4.89"},{"date":"2025-06-30","value":"11.47","vol":"5.24"},{"date":"2025-03-31","value":"10.22","vol":"6.33"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	10.69	11.23	11.73	11.47	10.22
行业	5.14	4.43	4.89	5.24	6.33

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 45/71 ， 46/71。

[{"date":"2026-03-31","value":"5.82","vol":"28.78"},{"date":"2025-12-31","value":"5.43","vol":"28.75"},{"date":"2025-09-30","value":"5.23","vol":"28.02"},{"date":"2025-06-30","value":"5.30","vol":"26.19"},{"date":"2025-03-31","value":"5.49","vol":"26.65"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	5.82	5.43	5.23	5.30	5.49
行业(%)	28.78	28.75	28.02	26.19	26.65

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.06","vol":"2.54"},{"date":"2025-12-31","value":"0.06","vol":"1.42"},{"date":"2025-09-30","value":"0.06","vol":"0.58"},{"date":"2025-06-30","value":"0.06","vol":"1.11"},{"date":"2025-03-31","value":"0.06","vol":"0.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.06	0.06	0.06	0.06	0.06
行业(%)	2.54	1.42	0.58	1.11	0.80

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"0.91","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.13","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.54","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.78","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[近岸蛋白]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]